Nebenwirkungen · Busulfan Fresenius Kabi
Busulfan Fresenius Kabi 6 mg/ml concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 8
HOS-130004 · Präparat HOS-096825
Infections and infestations 39% of patients (40/103) experienced one or more episodes of infection, of which 83% (33/40) were rated as mild or moderate. Pneumonia was fatal in 1% (1/103) and life-threatening in 3% of patients. Other infections were considered severe in 3% of patients. Fever was reported in 87% of patients and graded as mild/moderate in 84% and severe in 3%. 47% of patients experienced chills which were mild/moderate in 46% and severe in 1%.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-01T12:05:00Z · SHA-256 803007b850189812dae1406bc9fec1c869aaeaaacf0104c26b1fa84613ab3fe2 · Passage 9e74607289605b0d987b3423784193d4ff122a89485d0d5c9cc9a73235260edf · Zeichen 1440–1901 im Abschnitt